Autonomix signs key clinical agreements in preparation to begin march 2024 human clinical trial

Proof-of-concept (poc) human clinical trial targeting multi-billion-dollar pancreatic cancer market through transvascular rf ablation

AMIX Ratings Summary

AMIX Quant Ranking